0.88CNY
1.25 BCNY
5.48 BCNY
222.93 M
About BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD.
Sector
Industry
CEO
Zhiming Jiang
Website
Headquarters
Beijing
Employees (FY)
3.84 K
Founded
1991
ISIN
CNE100004090
FIGI
BBG00D70GDJ7
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. engages in the research and development, production, and sale of in vitro diagnostic reagents and equipment, and vaccines. It operates through the In Vitro Diagnostic Reagents and Vaccines segments. The In Vitro Diagnostic Reagents segment covers human immunodeficiency virus and viral hepatitis reagents, and automatic tubular chemiluminescence immunoassay systems. The Vaccines segment offers recombinant hepatitis E, human papillomavirus, and freeze-dried live attenuated varicella vaccines. The company was founded on April 24, 1991 and is headquartered in Beijing, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 603392 is 67.28 CNY — it has decreased by 4.15% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. stocks are traded under the ticker 603392.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. is going to release the next earnings report on Apr 26, 2024. Keep track of upcoming events with our Earnings Calendar.
603392 stock is 4.73% volatile and has beta coefficient of 2.08. Check out the list of the most volatile stocks — is BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. there?
One year price forecast for BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. has a max estimate of 58.00 CNY and a min estimate of 51.30 CNY.
603392 earnings for the last quarter are 0.86 CNY whereas the estimation was 0.93 CNY which accounts for −7.41% surprise. Estimated earnings for the next quarter are 1.07 CNY. See more details about BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. earnings.
Yes, you can track BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. financials in yearly and quarterly reports right on TradingView.
603392 stock has fallen by 9.28% compared to the previous week, the month change is a 8.65% fall, over the last year BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. has showed a 20.43% decrease.
603392 net income for the last quarter is −560.68 M CNY, while the quarter before that showed 106.01 M CNY of net income which accounts for −628.92% change. Track more BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. financial stats to get the full picture.
Today BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. has the market capitalization of 88.96 B, it has increased by 1.84% over the last week.
Yes, 603392 dividends are paid annually. The last dividend per share was 1.00 CNY. As of today, Dividend Yield (TTM)% is 0.73%. Tracking BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. dividends might help you take more informed decisions.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. dividend yield was 0.43% in 2023, and payout ratio reached 32.32%. The year before the numbers were 0.56% and 13.45% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 603392 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 3.84 K employees. See our rating of the largest employees — is BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. stock shows the sell signal. See more of BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. future price: according to them, 603392 price has a max estimate of 58.00 CNY and a min estimate of 51.30 CNY. Read a more detailed BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. forecast: see what analysts think of BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. EBITDA is 1.49 B CNY, and current EBITDA margin is 29.52%. See more stats in BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. financial statements.